Sestamibi as an alternative to mebrofenin for the diagnosis of acute cholecystitis: An alternative option during supply chain disruption

MLA

Bamidele Otemuyiwa, et al. “Sestamibi as an Alternative to Mebrofenin for the Diagnosis of Acute Cholecystitis: An Alternative Option during Supply Chain Disruption.” Heliyon, vol. 10, no. 10, May 2024. EBSCOhost, https://doi.org/10.1016/j.heliyon.2024.e31257.

APA

Bamidele Otemuyiwa, Matthew S. Davenport, Daniel J. Wale, Midhhath Afza Munavar Ali, & Benjamin L. Viglianti. (2024). Sestamibi as an alternative to mebrofenin for the diagnosis of acute cholecystitis: An alternative option during supply chain disruption. Heliyon, 10(10). https://doi.org/10.1016/j.heliyon.2024.e31257

Chicago

Bamidele Otemuyiwa, Matthew S. Davenport, Daniel J. Wale, Midhhath Afza Munavar Ali, and Benjamin L. Viglianti. 2024. “Sestamibi as an Alternative to Mebrofenin for the Diagnosis of Acute Cholecystitis: An Alternative Option during Supply Chain Disruption.” Heliyon 10 (10). doi:10.1016/j.heliyon.2024.e31257.